Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AM Rx vs Care Bare Rx

AM Rx
Graded #491

Lower grade

vs+25.4
Care Bare Rx
Graded #43

Higher grade

The verdict

Care Bare Rx takes it — 75/100 to 49.6/100.

Care Bare Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Oral as well as injectable routes for both molecules plus a brand Ozempic lane, bundled with hair, TRT and sexual health.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCare Bare Rx +18
50
68
Dose & formulationCare Bare Rx +29
65
94
Clinical oversightCare Bare Rx +33
41
74
Labs & monitoringCare Bare Rx +13
49
62
FulfillmentCare Bare Rx +20
58
78
Contract termsCare Bare Rx +52
20
72
AM Rx · left barCare Bare Rx · right bar

The numbers

MetricAM RxCare Bare Rx
WeighScore49.6/10075/100
GradeCC
Scorecard rank#491#43
Semaglutide$151/mo (quarterly plan, plus a separate fee, compounded)From $199/mo (shared weight-loss price)
TirzepatideNot disclosedFrom $199/mo (shared weight-loss price)
CoverageCoverage not publishedMulti-state
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
AM Rx

Graded #491 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available with providers averaging 10+ years' experience
  • Compounded semaglutide from $151/mo on the quarterly plan

Where it loses points

  • Active FTC/DOJ lawsuit over deceptive billing and subscription practices
  • Novo Nordisk false-advertising lawsuit (Aug 2025)
  • Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Care Bare Rx

Graded #43 · C

Strengths

  • Oral tirzepatide as well as injectable — rare on this board
  • Brand Ozempic (from $705/mo) and oral Rybelsus beside the compounded line
  • LegitScript certified and HIPAA compliant
  • One platform if you also want hair, TRT, sexual health or NAD+

Where it loses points

  • The advertised "from $199/mo" is one figure shared across all weight-loss treatments — neither molecule priced separately
  • Per-dose pricing is quiz-gated, so a titrated cost cannot be modelled beforehand
  • No named clinicians, founding year or parent company disclosed
  • Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard